BTAI vs OMC · rev $388.0K vs rev $17.27B
BioXcel Therapeutics Inc (BTAI) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
BTAI currently screens at market cap $36.1M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the BTAI and OMC stock pages for the full models.
Not investment advice.